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Abstract
Although lysyl-tRNA synthetase (KRS), an enzyme for protein
synthesis, is secreted from cancer cells to trigger inflammatory
responses, its secretion mechanism is not understood. Here we show
that KRS is secreted via exosomes from cancer cells. KRS is located
within the lumen of exosomes and released from the exosomes that
are ruptured near the target cells. The N-terminal 12 amino acid of
KRS was cleaved by caspase-8 upon starvation. The N-terminal
cleavage exposed the PDZ-binding motif located in its C-terminal
end. Syntenin bound to the exposed PDZ-binding motif of KRS and
facilitated the dissociation of KRS from multi-tRNA synthetase
complex for exosomic secretion. The isolated KRS-containing
exosomes induced migration and TNF-α secretion of macrophages
and KRS showed significant contribution to these activities. These
results suggest exosomes as a secretion vehicle for KRS and its
functional connection with caspase-8-mediated inflammation provoked
by cancer cells.
VI
Keywords : exosome, lysyl-trna synthetase, syntenin, caspase-8,
inflammation
Student number : 2010-31385
1
Introduction
Aminoacyl-tRNA syntetases (ARSs) are known as essential enzymes
for protein synthesis, charging amino acids to their cognate tRNAs
(Ibba and Soll, 2000). However, they are now newly recognized as
multi-faceted signal mediators, dynamically connected to diverse
signal pathways (Guo and Schimmel, 2013). Among them, many
activities involve the secretion of ARSs into extracellular space (Son
et al., 2014). The secreted ARSs have been reported to play roles in
the control of angiogenesis (Mirando et al., 2014), immune responses
(Han et al., 2007; Nechushtan et al., 2009; Park et al., 2005b)), tissue
regeneration (Park et al., 2005c) and tumorigenesis (Choi et al., 2011;
Park et al., 2005a; Park et al., 2012). However, it remains unanswered
how they are secreted. Among the secreted ARSs, KRS was
previously shown to be secreted from cancer cells to induce
inflammatory responses. To have an insight into secretion mechanism
of ARSs, here we focused on the secretion of KRS and investigated
in-depth how it is secreted from cancer cells.
Exosomes are small extracellular vesicles originating from the
2
endosome. Exosomes have established characteristics of 1.15-1.19g/ml
density, 50-150nm diameter, and cup-shape electronic microscopic
morphology (Bobrie and Thery, 2013). These exosomes have diverse
component - membrane protein, receptor, kinase, other cytosol protein,
microRNA, mRNA, tRNA, lipids and several other functions. It is an
important intracellular communication method. Exosomes transfer
cargo protein to recipient cells and contribute to immunological
processes in tumor progression and metastasis (Raposo and
Stoorvogel, 2013). These exosomes are generated from the endosome
that are produced by plasma membrane budding. Inward budding
makes multi-vesicular bodies (MVBs) and intraluminal vesicles
(ILVs). The formation of ILVs requires the endosomal sorting
complex for transport (ESCRT) machinery and these machinery
indicates ubiquitination of membrane protein, thereby inducing
intraluminal vesicles (Robbins and Morelli, 2014). Ceramide and other
lipids also induce exosome biogenesis through ESCRT independent
mechanism. Recently, a new mechanism of exosome biogenesis was
mentioned that syntenin controls the formation of exosome
ubiquitination independent manner (Baietti et al., 2012). The specific
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mechanism syntenin dependent exosome pathway is induced so that
the syntenin-syndecan complex interacts with ALIX through its
N-terminal LYPXnL motif. Since ALIX is an auxiliary component of
ESCRT, this interaction induces ESCRT machinery binding to
syntenin complex and produces ILV which has syndecan cargo
protein, like FGFR1, in MVB. In this sequential mechanism, syndecan
cleavaged by heparanse induces intraluminal budding of
syndecan-syntenin-alix and syndecan cargo protein complex in
endosomes (Roucourt et al., 2015). In previous report, we already
notice that PDZ domain of syntenin could interact with KRS
(Meerschaert et al., 2008). However, the function of KRS-syntenin
complex was not clear yet.
Caspase family is well known protease proteins in apoptosis and
inflammation. This protease family is classified into two sub-families;
one is regulator of inflammation (caspases-1, -4, -5, -12). and the
other is regulator of apoptosis (caspases-3, -6, -7, -8, -9)(Van
Damme et al., 2005; McIlwain et al., 2015). Among these, caspase-1
is the major protein that induces inflammation. Upon bacteria
infection, caspase-1 is activated and build inflammasome with
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different types of scaffolding proteins. These scaffolding proteins are
assembly of different inflammasomes depending on various specific
pathogen- or danger associated molecular patterns (PAMPs and
DAMPs). Assembled caspase-1 inflammasome cleaves pro-IL-1β,
pro-IL-18, pro-IL-33 to activate IL-1β, IL-18, IL-33. Canonical role
of caspase8 is initiating the apoptosis process. Fas ligand binds to
Fas receptor and induces pro caspase-8 cleavage. Caspase-8 truncates
pro-caspase-3 to caspase-3 and induces cell apoptosis. Beside
classical role of caspase 8 in apoptosis, its role in pro il 1b activation
was recently studied from other group. recently studies showed that
caspase-8 induced pro-IL-1β activation. Two hypothetical
mechanisms were mentioned; one is the caspase-8 inflammasome
dependent, another is caspase-8 inflammasome independent pathway.
Caspase-8 inflammasome dependent pathway starts with either fungi
or mycobacterium binding to dectin-1 and phosphorylates Syk kinase
(McIlwain et al., 2015; Gringhuis et al., 2012). Through PKCδ
activation, caspase-8 inflammasome is assembled with CARD9,
Bcl-10, MALT1, ASC. Activated caspase-8 inflammasome cleaves
pro- IL-1β to IL-1β. IL-1β secretion is dramatically reduced in
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caspase-8 -/-, Ripk3-/- dendritic cells compared with Ripk3-/- or
WT dendritic cell (Antonopoulos et al., 2013). Caspase-8
inflammasome independent pathway induces apoptotic signaling like
CD95L, and ER stress. In this signaling pathway, IL-1β secretion is
independent of caspase-8 inflammation components such as NLRP3,
NRC4, and ASC. This evidence mean caspase-8 can induce
inflammation and can regulate apoptosis and inflammation in immune
cell. Because caspase-8 is well-known apoptosis caspase, loss of
caspase-8 expression can help the cancer progression. Even some
cancer types are upregulated with caspase-8 expression level but its
reason is not yet unveiled.
Human cytosolic KRS is comprised of 574 amino acid (aa)
in which the anticodon-binding (S70-P214) and catalytic domains
(L220-K574) are embedded (Guo et al., 2008), (Fig. 1a). It also
contains a unique N-terminal extension (Guo et al., 2010). Human
KRS can undergo dynamic structural transformation guided by
specific phosphorylation to exert distinct roles. For instance, it is
phosphorylated at S207 in the activated mast cells (Ofir-Birin et
al., 2013; Yannay-Cohen et al., 2009). S207 is located at the
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junction of the two functional domains and its phosphorylation
pushes the two domains apart so that it does not work as the
enzyme for tRNA charging anymore. The resulting S207
phosphorylated KRS is then translocated into nucleus for
transcriptional control via MITF. Upon laminin treatment, KRS is
phosphorylated at T52 that is located in the N-terminal extension
that is unique for higher eukaryotic KRS. This phosphorylation
induces unfolding of the N-terminal extension that is then guided to
plasma membrane. The membrane-bound KRS can interact with
67kDa laminin receptor to promote cell migration (Kim et al., 2012)
and this function is also implicated in cancer metastasis (Kim et al.,
2014). In this work, we investigated how KRS is secreted to
extracellular space and whether any post-translational modification
would be involved in this process.
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Results
KRS secretion via exosomes
Since many proteins are secreted via ER-golgi pathway (Lacy and
Stow, 2011), we investigated whether the secretion of KRS would
also involve this pathway using Brefeldin A (BFA) that is the
inhibitor of the ER-Golgi secretion pathway (Rosa et al., 1992).
Following the previous report, we induced KRS secretion by
subjecting HCT116 cells to starvation (with and without TNF-α) and
checked how the BFA treatment would affect the secretion and found
that BFA did not affect KRS secretion (Fig 1B). Besides, we
examined the potential signal peptide in the N-terminal region of
KRS for the secretion through ER-Golgi pathway using SignalP
database (http://www.cbs.dtu.dk/services/signalP/) and found no clue
to the presence of signal peptide (data not shown). Instead, KRS
contains the PDZ domain-binding motif in its C-terminal end (Fabre
et al., 2000) (Fig. 1A) which can be used for the interaction with
syntenin that is known to be involved in exosome secretion (Baietti
et al., 2012; Meerschaert et al., 2008). Based on these results, we
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assumed that KRS may secrete via extracellular vesicles such as
exosomes.
To see whether the KRS secretion would involve secretory
vesicles, we subjected the complete and starvation culture media of
HCT116 cells to centrifugation at 100,000 g and obtained the pellet.
We then lysed the proteins from the isolated vesicles in the pellets
and checked the presence of KRS by immunoblotting with anti-KRS
antibody. Higher amount of KRS was detected in the vesicles isolated
from the starvation medium (Fig. 1C). We examined the condition
that can induce the secretion of KRS from HCT116 cells. Among all
the tested conditions (Starvation, Inflammation by TNF-α, Reactive
Oxygen Stress (ROS) by Sodium Arsenite (Barchowsky et al., 1999;
Ruiz-Ramos et al., 2009), Hypoxia by CoCl2(Piret et al., 2002) and ER
stress by Tunicamycin), KRS secretion was most prominent upon
starvation (Fig. 1D). Interestingly, the size of KRS in the vesicle
appeared to be smaller than that of the cytosolic KRS, suggesting a
potential peptide cleavage of KRS during the secretion process (see
below). Density-gradient centrifugation analyses of the isolated
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vesicles showed that KRS is harbored in the fractions with the
density range of 1.09 - 1.15 g/ml that also contained syntenin, a
factor crucial for exosome secretion (Baietti et al., 2012; Thery et al.,
2009) (Fig. 1E). Opti-prep gradient centrifugation suggested that the
KRS-containing vesicles would have an average of 147.3 nm in
diameter (Fig. 1F). We subjected the isolated vesicles to electron
microscopic analysis and found that they would have a typical cup
shape (Fig. 1G) that are morphologically similar to typical exosomes
(Thery et al., 2009).
We also investigated whether KRS secretion was affected by
suppression of Rab GTPases (Rab11a, Rab27a, Rab35) which have
been suggested to play a role in exosome shedding (Hsu et al., 2010;
Ostrowski et al., 2010; Savina et al., 2005). The KRS secretion was
differentially reduced by the suppression of Rab proteins (Fig. 2A),
implying that KRS-exosomes might be exported out of cells in a
Rab-dependent manner. Since ESCRT-III proteins were previoulsy
suggested to induce luminal vesicle formation of MVB and exosomic
secretion of syntenin (Baietti et al., 2012), we also examined whether
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KRS secretion would be affected by the suppression of ESCRT-III
proteins and observed the reduction of KRS and syntenin secretion
by the suppression of each ESCRT-III component (CHMP1a, 2a, 3,
4a, 4b, 6 and 7) (Fig. 2B). These results further support the
syntenin-dependent exosomal secretion pathway.
We then determined the location of KRS in the isolated
exosomes by electron microscopy with immunogold staining of KRS
and CD63, the typical membrane marker of exosome (Marzesco et al.,
2005; Thery et al., 2002), with their specific antibodies. While CD63
was located in the membrane of the isolated exosomes, KRS was
mostly located in the lumen (Fig. 3A, 3B). We further determined the
KRS topology in the isolated exosomes by trypsin treatment, and
observed that KRS and syntenin were resistant whereas CD63 was
sensitive to trypsin digest (Fig. 3C). These results further suggest
that KRS is localized within the lumen of isolated exosomes.
The naked KRS was previously shown to activate macrophages.
To determine whether KRS in the lumen of exosomes can activate
macrophages, we treated macrophages with KRS-containing exosomes
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and followed the movement of KRS from exosomes to macrophages
by immunogold-staining electron microscopy. KRS located in the
lumen of exosomes (Fig. 3D) was released by the rupture of the
exosomes (Fig. 3E) and introduced into macrophages (Fig. 3F).
To further confirm this observation, we expressed C-terminally
Myc-tagged KRS (KRS-Myc) in HCT116 cells and prepared
exosomes harboring KRS-Myc. We then treated macrophages with
these exosomes and monitored whether KRS-Myc was sensitive to
proteolytic cleavage. If KRS-Myc would be taken up to macrophages
as naked protein, it would be sensitive to proteolytic cleavage. We
did not detect intact KRS-Myc in macrophages that were assayed at
different time intervals, (Fig. 3G), further supporting the electron
microscopic observation.
To determine whether KRS is specifically recruited to the
starvation-induced exosomes, we examined the presence of nine
different ARSs and found only KRS in the isolated exosomes (Fig.
4A), suggesting the preferential recruitment of KRS to
starvation-induced exosomes. We also tested several different cancer
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cell lines for the secretion of KRS- exosomes and found that MCF7
cells also secreted KRS (Fig. 4B).
Requirement of syntenin for KRS secretion
A potential interaction of KRS was previously suggested with
syntenin that plays a crucial role in exosome biogenesis and secretion
(Baietti et al., 2012; Meerschaert et al., 2008). We thus investigated
whether syntenin would indeed play a role in the secretion of KRS.
First, we performed co-immunoprecipitation assay of syntenin and
KRS in the complete, starved and TNF-α treatment conditions. The
starvation condition (with and without TNF-α) increased the
interaction of the two proteins compared to that of the complete
medium (Fig. 5A). The cellular interaction of the two proteins was
also monitored by BiFC (Bimolecular Fluorescence Complementation)
assay using green fluorescence Venus protein. The 173aa N- and
155aa C-terminal fragments of Venus were fused to the C-terminal
ends of KRS and syntenin, respectively. The interaction of the two
proteins would restore Venus green fluorescence while either alone
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would not. We incubated HCT116 cells expressing the two fusion
proteins, KRS-VN173 and syntenin-VC155 in the complete and
starvation media and the generation of green fluorescence was
measured. The fluorescence was only observed in the starvation
condition (Fig. 5B). To see whether syntenin is required for KRS
secretion, we suppressed the cellular levels of syntenin with its
specific siRNA and checked the effect on the KRS secretion. The
amount of secreted KRS was decreased when syntenin was
suppressed with its siRNA in dose-dependent manner (Fig. 5C). The
syntenin knockdown also decreased the amount of KRS as well as
syntenin itself in the isolated exosomes (Fig. 5D).
To see whether the C-terminal PDZ-binding motif of KRS is
critical for the syntenin binding and exosomic secretion of KRS, we
first compared the interaction of KRS WT and the C-terminal 5aa
deleted mutant (△C5) with syntenin by co-immunoprecipitation and
found that KRS △C5 mutant showed the reduced ability to bind to
syntenin (Fig. 5E). We then examined whether KRS WT and △C5
mutant would show difference in secretion and found that the deletion
14
of PDZ-binding motif reduced the secretion and exosome
incorporation ability of KRS (Fig. 5F and G, respectively). To further
validate the importance of the PDZ-binding motif, we introduced
alanine substitutions to the four C-terminal residues (C4A mutant)
(Manes et al., 2010; Wieman et al., 2009), and monitored how these
mutations affected recruitment of KRS into exosomes. The amount of
KRS C4A mutant was significantly lower than that of KRS WT in
the isolated exosomes (Fig. 5H). All of these results suggest that
syntenin binding to the C-terminal PDZ-binding motif facilitates
exosomic secretion of KRS.
The role of the KRS N-terminus in secretion
We found that KRS isolated from the isolated exosomes moved faster
in gel electrophoresis than cytosolic KRS, suggesting that a portion
of KRS might be cleaved off during the secretion process (Fig. 6A).
To determine the cleavage site, we expressed KRS with Myc tag
fused at the N- or C-terminal end in HCT116 cells and subjected
KRS in the secreted exosomes to immunoblot analysis with anti-Myc
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antibody. While we detected KRS-Myc (fused to the C-terminal) but
not Myc-KRS (fused to the N-terminal) (Fig. 6B), implying that the
N-terminal end would be truncated. We also prepared the
double-tagged form of KRS in which Strep and Myc tags were fused
to the N- and C-terminal ends, respectively, and expressed it in
HCT116 cells. The secreted KRS was detected with anti-Myc but not
with anti-Strep antibody (Fig. 6C), further supporting the N-terminal
cleavage of KRS for secretion. Next, we attached the N- and
C-terminal domains of Renilla luciferase (Kerppola, 2008; Ofir-Birin et
al., 2013) to the N- and C-terminal ends of KRS, respectively, and
used this fusion protein to monitor the secretion-induced KRS
cleavage. While the intact KRS would bring the two domains of
Renilla luciferase into proximity to recover the luciferase activity, the
cleavage of KRS would ablate the Binary Fluorescence
Complementation (BiFC) of the two Renilla luciferase domains. Indeed,
as HCT116 cells were starved, the BiFC signal was decreased in
time-dependent manner (Fig. 6D). We then expressed the GFP-KRS
fusion protein in HCT116 cells and incubated the cells in the
starvation condition. The cytosolic emergence of GFP resulting from
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the cleavage of GFP-KRS showed the similar kinetic pattern to that
of KRS secretion (Fig. 6E). All of these results indicate that KRS is
cleaved at its N-terminal region for secretion.
We next determined the exact cleavage location in KRS. We
first prepared a series of the N-terminal deletion mutants of
Myc-KRS and compared the effects of the deletion on KRS secretion.
Among the tested mutants, the secretion of KRS mutants, △N20,
△N30 and △N40 (the N-terminal 20, 30 and 40aa deleted,
respectively) was observed, but not KRS WT and mutant △N10
(Fig. 7A), suggesting that the N-terminal cleavage would occur
somewhere from the 11th to 20th residue. We further prepared the
Myc-KRS mutants, △N11 and △N12 and conducted the same
experiments above, and found that Myc-KRS △N12, but not △N10
and △N11, was detected (Fig. 7B). Combined together, the results
suggest that the secretion-induced cleavage should occur between at
the 12th residue. To further confirm this, we mutated aspartic acid
residue at the position of 12 to alanine (D12A) and checked whether
this mutation would affect the secretion of KRS. KRS-Myc D12A
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mutant was not detected in the culture medium, indicating that the
mutation deprived the ability of secretion (Fig. 7C). We also
monitored the secretion-induced cleavage of this mutant using BiFC
Renilla luciferase as above. The Renilla luciferase activity was
reduced by starvation in KRS WT, but not in the D12A mutant (Fig.
7D). Likewise, the starvation-induced cleavage of GFP-KRS was also
not observed in GFP-KRS D12A mutant in contrast to GFP-KRS
WT (Fig. 7E). When we subjected Myc-KRS WT and△N12 mutant
isolated from the secreted exosomes to immunoblotting with anti-Myc
antibody and found only Myc-KRS △N12, but not WT, further
indicating that the cleavage would occur at D12 position (Fig. 7F).
Comparison of KRS-Myc WT and D12A mutant for exosome
incorporation, only KRS WT was detected in the isolated exosomes,
further confirming the importance of D12 cleavage for the exosome
incorporation and secretion of KRS (Fig. 7G).
The role of caspase-8-mediated N-terminal cleavage in syntenin
interaction
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We next determined the enzyme responsible for the cleavage of the
N-terminal 12aa of KRS for its secretion. Interestingly, the
N-terminal peptide of KRS contains the consensus caspase
(V-X-X-D especially for 3, 6 and 8) substrate sequence (Van
Damme et al., 2005) (Fig. 1A). To determine whether any of the
known caspases is required for the N-terminal truncation and
secretion of KRS, we treated HCT116 cells with Pan-caspase
inhibitor and checked its effect on KRS secretion and KRS truncation.
The starvation-induced KRS secretion and truncation were
significantly inhibited by the treatment of Pan-caspase inhibitor (Fig.
8A, 8B), suggesting the involvement of caspase activity for the
secretion. To determine the caspase that is responsible for the KRS
cleavage, we suppressed one of caspases-3, -6, -8 and -9 with their
specific siRNAs and specific caspase inhibitor compared their effects
on the secretion of KRS. Among them, the knockdown and inhibitor
of caspase-8 specifically blocked the KRS secretion (Fig. 8C, 8D). We
also observed the KRS level in the exosomes was reduced when
HCT116 cells were treated with caspase-8 inhibitor (Z-VAD-IETD)
(Fig. 8E). The effect of caspase 8 inhibitor on the KRS cleavage was
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also monitored using BiFC Renilla luciferase-fused KRS and
GFP-KRS truncation. The Renilla luciferase activity was reduced by
starvation, but recovered by the treatment of caspase-8 inhibitor (Fig.
8F). And also GFP-KRS truncation was increased by starvation, but
recovered by the treatment of caspase-8 inhibitor (Fig. 8G). We next
examined whether the expression level of caspase-8 is affected by
starvation, and found that caspase-8 level is specifically increased
upon starvation in time-dependent manner while the levels of other
caspases did not (Fig. 8H). We also found that the exogenously
introduced caspase-8 increased the levels of secreted KRS in
dose-dependent manner (Fig. 8I). Then, we investigated whether
inhibition of caspase-8 would affect the interaction of KRS with
syntenin by co-immunoprecipitation and found that the
starvation-induced interaction of the two proteins was inhibited by
the treatment of caspase-8 inhibitor (Fig. 9A), suggesting the
importance of the caspase-8 cleavage of the KRS N-terminal peptide
for the interaction of KRS with syntenin. We also compared the
interaction of KRS WT and D12A mutant with syntenin by
co-immunoprecipitation in starvation condition and found that the
20
D12A mutant showed reduced interaction with syntenin (Fig. 9B).
The starvation-induced interaction of the two proteins was also
observed by BiFC as above and the effects of D12A mutation and
caspase 8 inhibition on the interaction was examined. In contrast to
the pair of KRS WT and syntenin, KRS D12A mutation or
Z-VAD-IETD treatment inhibited the generation of green fluorescence
(Fig. 9C). Combined together, caspase-8 was identified as the enzyme
responsible for the cleavage at D12 of KRS that facilitates its
interaction with syntenin and secretion.
Syntenin-dependent dissociation of KRS from multi-tRNA
synthetase complex
A majority of KRS would exist as a component of the multi-tRNA
synthetase complex (MSC) in cytosol. We thus investigated whether
the secretion of KRS would require its dissociation from MSC using
gel filtration chromatography. When proteins extracted from HCT116
cells (complete and starvation condition) were subjected to gel
filtration, starvation-induced dissociation of KRS from MSC was
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increased, but not of EPRS, another component of MSC that is
known to be dissociated from MSC by IFN-γ (Sampath et al., 2004)
(Fig. 10A). We then examined whether the N12aa truncation would
affect the dissociation of KRS from MSC. We starved HCT116 cells
in the absence and presence of caspase-8 inhibitor and cellular MSC
was immunoprecipitated with anti-EPRS antibody. The portion of
KRS not bound to MSC was detected by immunoblotting of KRS
remained in the immune-depleted supernatants after removing the
immunoprecipitates. The KRS present in the immune-depleted fraction
was decreased by the treatment of caspase-8 inhibitor (Fig. 10B),
suggesting that caspase-8-mediated N-terminal cleavage of KRS can
enhance the dissociation of KRS from MSC. Using the same method,
we examined whether the DN12 or cleavage-defective D12A mutation
and syntenin would affect the dissociation of KRS from MSC. In
contrast to KRS WT and DN12 mutant, KRS D12A mutant was not
detected in the immune-depleted supernatants (Fig. 10C). Also,
knockdown of syntenin reduced the amount of KRS in the
immune-depleted fractions. We also compared the starvation-induced
dissociation of KRS WT and △C5 mutant from MSC as above, and
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found that the △C5 mutant level was significantly reduced in the
immune-depleted fraction (Fig. 10D). All these results suggest that
the caspase 8-mediated N-terminal cleavage of KRS and the
interaction of the resulting KRS with syntenin would facilitate the
dissociation of KRS from MSC.
Knowing that syntenin would facilitate the dissociation of
KRS from MSC and its extracellular secretion through exosome, we
further investigated whether syntenin can guide KRS to Alix, the
known marker for multivesicular body (MVB) (Baietti et al., 2012;
Matsuo et al., 2004; Odorizzi, 2006), from which exosomes are
secreted. For this, we visualized the KRS-syntenin complex using
BiFC method as above and tested whether the BiFC green
fluorescence signals (resulting from the complex formation between
KRS and syntenin) are co-localized with Alix that was labeled with
mCherry (red fluorescence). The KRS-syntenin complex (green
fluorescence) was generated upon starvation as shown before and it
was co-localized with the fraction of mCherry-Alix (Fig. 10E),
suggesting that syntenin can guide the N-terminal cleaved KRS from
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MSC to MVB. Since Alix is known to generate intraluminal vesicles
(ILV) in MVB with the client proteins from endosome, we checked
again whether KRS is located in the vesicles harbored within MVB
using immunogold-staining EM with anti-KRS antibody as above.
The KRS-specific immunogold particles were enriched in the vesicles
located within MVB of the HC116 cells under starvation (Fig. 10F),
suggesting that KRS-containing vesicles are formed within MVB.
Inflammatory activity of KRS-harboring exosomes
KRS secreted from cancer cells was previously shown to trigger
inflammatory responses when it was treated to macrophages (Park et
al., 2005b). Here we observed that KRS can be released from the
exosomes and introduced macrophages (Fig. 3D-F), suggesting that
these exosomes would exert the extracellular activities shown by the
naked KRS. We thus compared the naked KRS WT, DN12 mutant
protein and KRS-containing exosomes in their ability to induce
various cytokines and factors that are the known markers for M1-
and M2-type macrophages, and found that they all showed the
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similar activities, inducing TNF-α, CRG-2, IL6 and MMP9 from
RAW 264.7 cells (Fig. 11A, 11B) that are the signatures for M1-type
macrophages (Mantovani et al., 2002) with EC50 values of 83.4 nM
(KRS WT protein), 70.7 nM (KRS △N12 mutant) and 2.89 mg/ml
(KRS-exosome) (Fig. 11C). They also induced macrophage migration
(Fig. 11D). These results suggest that the truncation of the
N-terminal 12aa did not ablate the immune stimulatory activity of
KRS WT and KRS-containing exosomes would be functionally
equivalent to the naked KRS in inducing M1 polarization of
macrophages. To evaluate the functional significance of KRS in the
isolated exosomes, we compared the abilities of the isolated exosomes
from the si-control and si-KRS-treated HCT116 cells to induce
TNF-α. Knockdown of KRS with its specific si-KRS significantly
reduced the content of KRS in exosomes while not affecting those of
other components such as syntenin and Alix (Fig. 12A). The
exosomes obtained from the si-KRS-treated cells showed reduced
TNF-α-inducing and macrophage migration activities compared to
those of si-control-treated cells (Fig. 12B, 12C). To confirm these
data in vivo, we monitored the effect of the isolated exosomes from
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the si-KRS and si-control cells on the migration of macrophages and
neutrophils in vivo by intravital confocal microscopy using
GFP-LysM mice in which the mobility of macrophages and
monocytes can be monitored by green fluorescence (Choe et al., 2013;
Faust et al., 2000). When we first injected the naked KRS (labeled as
red fluorescence) in vivo, we observed that the injected KRS
attracted significantly enhanced immune cells compared with BSA
(Fig. 12D-E). Similarly, the exosomes isolated from the si-control and
si-KRS-treated HCT116 cells were labeled with red fluorescence DiI
and injected into GFP-LysM mice. The si-control exosomes induced
infiltration of macrophages and monocytes more strongly compared to
si-KRS exosomes and BSA (Fig. 12F-G). Using the same method,
we further compared the immune cell attracting effects of the cells
expressing EV, KRS WT and D12A mutant. After confirming that
KRS D12A mutant showed the reduced capability of secretion (Fig.
12H), we observed that the cells expressing this mutant showed the
reduced immune cell attracting capability compared to those
expressing KRS WT (Fig. 12I-J).
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Fig. 1. KRS secretion via exosomes. (A) Human cytosolic KRS
(597aa) consists of anticodon-binding (ABD, 70-214aa) and catalytic
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domains (CD, 222-574aa) (Guo et al., 2008). The caspase-8 cleavage
site (VxxD) and PDZ-binding motif (VGTSV) are located in the N-
(9-12aa) and C-terminal (594-597aa) ends. (B) HCT116 cells were
pre-treated with brefeldin A (2.5 mg/ml) and incubated in starvation
condition with or without TNF-α (10 ng/ml). The secretion of KRS
from HCT116 cells was determined by immunoblotting of KRS in
harvested media after 12 h of starvation. (C) HCT116 cells were
incubated in normal and starvation condition for 24 h. The culture
medium were subjected to ultra-centrifugation at 100,000 g to obtain
the pellet. KRS present in the pellets (containing vesicle fraction) was
separated by 8% PAGE and detected by immunoblotting with
anti-KRS antibody. Notice a slight difference in the gel mobility of
KRS in the medium and cell lysates (see below for further
investigation). WCL: whole cell lysates. (D) HCT116 cells were
subjected to starvation and to treatment with TNF-α (10 ng/ml),
Sodium Arsenite (12.5 mM), CoCl2(100mM), and Tunicamycin (2
mg/ml) in complete media to induce inflammatory, ROS (Barchowsky
et al., 1999; Ruiz-Ramos et al., 2009), Hypoxic (Piret et al., 2002) and
ER stresses, respectively. Extracellular vesicles secreted into the
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media were obtained by ultracentrifugation as described in Methods
and the presence of KRS was determined by immunoblotting of
proteins within the vesicles. (E) The isolated vesicles above were
separated by Opti-prep gradient centrifugation. The nine fractions in
the 1.02-1.19 g/ml density range were collected, and the presence of
KRS and syntenin analyzed by immunoblotting with their specific
antibodies. (F) Dynamic light scattering demonstrated the size
distribution of the isolated vesicles (mean diameter: 147.3nm). (G)
Negatively stained field of the KRS-containing vesicles isolated from
HCT116 cells as above. Bar, 200 nm
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Fig. 2. KRS secreted classical exosomal pathway. (A-B) To see
whether KRS exosomic secreton involved Rab (A) and ESCRT-III
proteins (B), we transfected siRNAs targeting each of the indicated
Rab and ESCRT-III proteins in HCT116 cells and examined whether
Rab, ESCRT-III proteins affected to KRS secretion. The secretion of
KRS was induced by starvation of HCT116 cells for 24 h. After
isolation of the exosomes, the amounts of KRS in the obtained
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exosomes were compared by immunoblotting with anti-KRS antibody.
Quantitation of secreted KRS blots was measured by ImageJ.
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Fig. 3. KRS located inside of exosome lumen. (A-B) Localization
of KRS (A) and CD63 (B), a known membrane-bound marker for
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exosomes, was shown by immunogold-staining electron microscopy
with their respective antibodies. Bars, 100 nm. (C) The isolated
vesicles were incubated with or without 0.025% trypsin, 0.1% triton
X-100 at 37°C for 30 min and the presence of KRS, syntenin, and
CD63 was analyzed by immunoblotting with their specific antibodies.
(D-F) Immunogold-staining electron microscopy shows KRS in the
lumen of the exosome near the target macrophage (I), the release of
KRS from ruptured exosomes, and uptake into the target macrophage
(J and K). Bars, 100 nm. (G) Exosomes were isolated from HCT116
cells transfected with KRS-Myc, and incubated with macrophages.
The exosome-treated macrophages were harvested at time intervals
and KRS present in macrophages was then detected by
immunoblotting with anti-Myc antibody to see whether KRS-Myc in
the exosomes was present as the intact form.
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Fig. 4. Determination of exosomal secretion of ARSs and
exosome secretion of KRS in different cell lines. (A) HCT116
cells were incubated in normal and starvation conditions for 24 h.
The culture medium was harvested and subjected to
ultra-centrifugation at 100,000 g to obtain a pellet. The presence of
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different ARSs in the isolated exosomes was detected by
immunoblotting with their specific antibodies. (B) The indicated
cancer cells were incubated in starvation condition for 24 h. The
culture medium was harvested and subjected to ultra-centrifugation
at 100,000 g to obtain a pellet. KRS present in the isolated exosomes
(10 ug total proteins) was detected by immunoblotting with anti-KRS
antibody.
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Fig. 5. Interaction of KRS with syntenin for secretion. (A)
HCT116 cells were incubated in the starvation condition in the
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absence and presence of TNF-α, and the interaction of KRS with
syntenin was determined by co-immunoprecipitation with an
anti-syntenin antibody. (B) The cellular interaction of KRS and
syntenin was determined by Bimolecular Fluorescence
Complementation (BiFC). HCT116 cells were co-transfected with
Flag-KRS fused toVN173 (Venus N-terminal domain), and
HA-syntenin fused to VC155 (Venus C-terminal domain). The cells
were incubated in normal and starvation conditions for 6 h and
reconstitution of Venus green fluorescence was shown by
fluorescence microscopy. Expression of KRS was observed by red
fluorescence signal from Alexa Fluor 594-conjugated anti-Flag
antibody (60X). Nuclei were visualized by DAPI staining (blue). Bar,
10 mm. (C) Secreted KRS and syntenin were detected by
immunoblotting of proteins from HCT116 cells treated with different
amounts of si-RNA against syntenin. The cells were incubated in
starvation condition for 24 h. Secreted proteins were precipitated with
TCA and the amounts of KRS determined by immunoblotting. (D)
The levels of KRS were also determined, as described above, in
isolated exosomes and cell lysates of HCT116 cells transfected with
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si-RNA against syntenin. (E) Interaction of KRS-Myc (WT, △C5:
C-terminal 5aa deleted mutant) with syntenin was determined by
co-immunoprecipitation from HCT116 cells after 1 h incubation in the
starvation condition. Syntenin was precipitated from whole cell lysates
with its specific antibody and the co-precipitated KRS was
immunoblotted with anti-Myc antibody. (F) Secretion of KRS (WT,
△C5) from HCT116 cells was determined in the 24 h-starvation
media as above. (G) The amounts of KRS WT and △C5 were
determined by immunoblotting in the exosomes isolated from HCT116
cells incubated in the starvation condition as above. (H) KRS mutant
in which the last four amino acids, GTSV, were changed to alanine
(C4A) was constructed. KRS WT and the C4A mutant secretion from
HCT116 cells starved for 24 h, as described above, was compared.
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Fig. 6. The effect of an N-terminal truncation of KRS on
secretion. (A) Secreted exosomes were isolated from the complete
and starved media of HCT116 cells, and KRS in the exosomes and
whole cell lysates was separated by 6% PAGE and detected by
immunoblotting. (B) To determine the truncation site, HCT116 cells
expressing either Myc-KRS (Myc tag fused to the N-terminal end of
KRS) or KRS-Myc (Myc tag fused the C-terminal end of KRS)
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were incubated in the starvation condition, and the exosomes were
isolated from medium. KRS in the exosomes was detected with
anti-Myc antibody. (C) HCT116 cells expressing Strep-KRS-Myc
(containing Strep and Myc tags at the N- and C-terminal ends,
respectively) were incubated in normal and starvation conditions for
24 h, and KRS in cytosol and exosomes was detected by
immunoblotting with anti-Myc and -Strep antibodies, respectively.
Syntenin, Alix, and HSP90 were used as markers for exosomes and
tubulin for cytosol. (D) To quantify the N-terminal truncation of
KRS, we fused the two domains of Renilla luciferase to each end of
KRS (N-Renilla-KRS-C-Renilla) and expressed it in HCT116 cells
under starvation conditions. The Renilla luciferase activities relative to
those of firefly luciferase were determined at time intervals and
displayed as a bar graph. n=3. *, P<0.05. **, P<0.01. (E) HCT116
cells expressing GFP-KRS were incubated in the starvation condition,
and harvested at indicated time intervals. The amount of GFP-KRS
and KRS secreted into the medium and in whole cell lysates was
determined by immunoblotting with anti-KRS and -GFP antibodies,
respectively.
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Fig. 7. Determination of KRS N-terminal truncation site. (A)
HCT116 cells expressing each Myc-KRS variant (WT, △N10, △N20,
△N30 and △N40) were incubated in the starvation medium for 24 h,
and the secreted KRS was precipitated with TCA and subjected to
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immunoblotting with anti-Myc antibody. (B) The same experiments
were conducted with Myc-KRS △N10, △N11 and △N12. (C)
KRS-Myc WT and D12A mutant proteins were expressed in HCT116
cells and their secretion determined by immunoblotting with anti-Myc
antibody. (D) Effects of starvation and D12A mutation on the
N-terminal cleavage of KRS were also monitored using Renilla
luciferase assay as above. n=3. *, P<0.05. **, P<0.01. (E) Effect of
D12A mutation on starvation-induced N-terminal cleavage of KRS
was determined using GFP-KRS fusion protein expressed in HCT116
cells. (F) Myc-KRS WT and △N12 mutant were expressed in
HCT116 cells and their incorporation into the secreted exosomes
during 24 h starvation was determined by immunoblotting with
anti-Myc antibody. (G) The same experiments were conducted as
above with KRS WT and D12A mutant.
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Fig. 8. N-terminal truncation of KRS by caspase-8. (A) Starved
HCT116 cells were treated for 24 h with the pan-caspase inhibitor,
Z-VAD-FMK, and secreted KRS was precipitated with TCA and
detected by immunoblotting with anti-KRS antibody. (B) HCT116
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cells expressing GFP-KRS were incubated in starvation medium in
the absence and presence of pan-caspase inhibitor for 1 h. Cleavage
of KRS was monitored by immunoblotting with anti-GFP antibody.
(C) HCT116 cells were transfected with caspase-specific siRNAs and
their effect on KRS secretion was determined by immunoblotting with
anti-KRS antibody. (D) The starvation-induced secretion of KRS
from HCT116 cells was determined by immunoblotting of the media
in the presence of specific caspase inhibitors (Z-VAD-DQMD,
Z-VAD-VEID, Z-VAD-IETD and Z-VAD-LEHD for caspase-3, -6,
-8 and -9, respectively). Proteins in the media were precipitated with
TCA and KRS levels were determined by immunoblotting with
anti-KRS antibody. (E) The effect of a specific caspase-8 inhibitor,
Z-VAD-IETD, on KRS secretion was determined by immunoblotting
of the exosomes isolated. (F) The effect of the caspase-8 inhibitor on
the N-terminal truncation of KRS was determined using KRS
containing two domains of Renilla luciferase, one fused to each end.
Firefly luciferase was used to monitor transfection efficiency. n=3. *,
P<0.05. **, P<0.01. (G) HCT116 cells expressing GFP-KRS WT
incubated in normal and starvation conditions were subjected to
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caspase-8 inhibitor (Z-VAD-IETD) treatment for 1 h and the
cleavage of GFP-KRS was determined by immunoblotting with
anti-GFP antibody. (H) The effect of starvation on the expression
levels of different caspases in HCT116 cells was determined by
immunoblotting with their specific antibodies. (I) Different amounts of
caspase-8 were expressed in the starved HCT116 cells, and its
dose-dependent effect on secretion of KRS was determined.
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Fig. 9. N-terminal truncation of KRS is required for
KRS-syntenin complex. (A) The effect of the caspase-8 inhibitor
on the starvation-induced interaction of endogenous KRS and
syntenin was determined by co-immunoprecipitation of HCT116 cell
lysates using anti-syntenin and -KRS antibodies. (B) The effect of
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the KRS D12A mutation on KRS interaction with syntenin was
determined by co-immunoprecipitation. (C) The effect of caspase-8
inhibitor on the cellular interaction of the Flag-KRS (WT,
D12A)-Venus (N-domain) and HA-syntenin-Venus (C-domain) in
starved HCT116 cells was monitored by BiFC experiment as
described above (60X). Bar, 10 mm.
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Fig. 10. Translocation of KRS from multi-tRNA synthetase
complex to exosomes. (A) Dissociation of KRS and EPRS from
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multi-tRNA synthetase complex (MSC) was monitored by gel
filtration of proteins that were extracted from HCT116 cells incubated
in the normal and starvation conditions. EPRS is a known component
of MSC (Quevillon et al., 1999). (B) The effect of caspase-8 inhibitor
(Z-VAD-ETD) on the starvation-induced dissociation of KRS from
MSC in HCT116 cells was determined by co-immunoprecipitation of
KRS and EPRS. The proportion of KRS dissociated from MSC was
determined by immunoblotting the supernatant (ID) after removing
the co-immunoprecipitates of KRS and EPRS (IP). The cellular levels
of KRS and EPRS were determined in whole cell lysates (WCL).
100% and 15% of IP and ID samples were loaded for gel
electrophoresis, respectively. (C) The effects of △N12 and D12A
mutations and syntenin knockdown on the dissociation of KRS-Myc
from MSC were determined as above. (D) The effect of △C5 (the
C-terminal 5 amino acid deletion) on the dissociation of KRS-Myc
from MSC were determined as above. (E) The effect of caspase-8
inhibitor on the association and co-localization of KRS-syntenin-Alix
was shown by BiFC and fluorescence microscopy, respectively. The
starvation-induced association of KRS and syntenin was shown by
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BiFC (green) as described in Fig. 2B. The localization of
KRS-syntenin complexes revealed by BiFC was further analyzed with
mCherry-Alix (red). Nuclei were visualized by DAPI staining (blue).
Bar, 10 mm. (F) Immunogold-staining electron microscopic analysis
showing the localization of KRS in vesicles located within the
multivesicular body (MVB) of HCT116 cells under starvation
condition. Arrowheads in each panel indicate the localization of
immunogold-labeled KRS. Bars: (F1) 200 nm, (F2) 100 nm, (F3)
200nm, (F4) 200 nm.
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Fig. 11. Biological activities of KRS-containing exosomes. (A)
Effects of KRS WT (6 mg), △N12 (6 mg) and KRS exosomes (5 mg
by total proteins) on the secretion of the indicated factors from RAW
264.7 cells were determined using multiplex bead array. n=3. *,
P<0.05. **, P<0.01. (B) The dose-dependent effect of KRS-exosomes
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on the secretion of TNF-α from RAW 264.7 cells (0.1, 1 and 5
mg/ml). KRS WT and △N12 mutant (6 mg/ml) were used as the
positive control. The secretion of TNF-α was quantified using a
TNF-α-specific ELISA. (C) The dose-dependent effects of KRS WT
and △N12 mutant (10, 50, 100, 200, 500nM), and KRS-exosomes (0.5,
1, 2, 5, 10 ug/ml) on the secretion of TNF-a from RAW 264.7 cells
were determined. The secretion of TNF-a was quantified using a
TNF-a-specific ELISA. n=3. *, P<0.05. **, P<0.01. (D) The effects
of KRS-exosomes, and KRS WT and △N12 mutants on the
migration of RAW 264.7 cells were determined by a wound-healing
assay (Liang et al., 2007). RAW 264.7 cells were scratched and
treated with KRS proteins (WT, △N12) and KRS-exosomes. After 12
h incubation, cell migration was monitored by microscopy. Bars, 100
mm.
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Fig. 12. KRS is essential factor for exosomal inflammatory
activities. (A) To assess the functional importance of KRS for
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exosomes, we reduced the KRS level in exosomes by siRNA
knockdown and confirmed by immunoblotting. TNF-α-inducing (B)
and transwell migration (C) activities of RAW 264.7 cells were
compared for purified KRS △N12 mutant (6 mg) and exosomes
(normal and KRS-suppressed, 5 mg total proteins) obtained from
HCT116 cells. n=3. *, P<0.05. **, P<0.01. (D) KRS WT and BSA
were labeled with DiI (red) and injected into mouse ear dermis (0.1
mg/ml). The recruitment of macrophages/monocytes (green) was
monitored by time-lapse intravital microscopy. Bars, 100 mm. (E)
These experiments were repeated three times and the results were
represented as bar graph with standard deviation. Green fluorescence
signal was measured by ImageJ. n=3. *, P<0.05. **, P<0.01. (F)
Exosomes (normal and KRS-suppressed, 0.1 mg/ml) from HCT116
cells and bovine serum albumin (BSA) were stained with DiI (red
fluorescence, (Potter et al., 1996)) and injected into mouse ear dermis.
To visualize macrophage/neutrophil (green fluorescence) recruitment
to the injection sites, time-lapse intravital images of
macrophage/neutrophil (green fluorescence) recruitment were taken in
30 sec intervals up to 120 min after injection. Bars, 100 mm. (G)
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These experiments were repeated three times and the results were
shown as bar graph with standard deviation. Green fluorescence
signal was measured by ImageJ. n=3. *, P<0.05. **, P<0.01. (H) The
secretion of KRS from B16F10 cells expressing KRS-Myc (WT and
D12A mutant) was determined by immunoblotting of harvested media.
(I-J) B16F10 cells expressing KRS WT and D12A mutant were
stained with DiD and injected into mouse ear dermis (4x104cells/ml,
red fluorescence). Bars, 100 mm. These experiments were repeated
three times and the results were shown as bar graph with standard
deviation. Green fluorescence signal was measured by ImageJ. n=3. *,
P<0.05. **, P<0.01.
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Fig. 13. Schematic working model of KRS secretion, in which two
monomers of KRS bind in an antiparallel fashion to form a
homodimer. In this dimer, the N-terminal 12aa of KRS (blue) blocks
the exposure of the PDZ-binding motif located at the C-terminal end
(red) in the counterpart monomer. Starvation-induced caspase-8
cleaves off the N-terminal 12aa to reveal the PDZ-binding motif so
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that syntenin can dock. Syntenin (green) binding induces the
dissociation of KRS from MSC and translocation to the MVB
(multivesicular body). The KRS-containing exosomes rupture near




Although many ARSs have been reported to be secreted (Son et al.,
2014), their secretion pathways remained unanswered. In this work,
we demonstrated that KRS is secreted via typical exosomes.
Besides this discovery, the secretion process of KRS provides a few
unexpected findings. First, a communication between the N- and
C-terminal ends of KRS is functionally involved its secretion. Based
on the known crystal structure of KRS in which the two monomers
of KRS would exist as anti-parallel homodimer (Ofir-Birin et al.,
2013), the N- and C-terminal ends of the two KRS monomers
would be in close proximity through dimerization. Thus, the
N-terminal peptide region of KRS might mask the PDZ-binding
motif located in the C-terminal end of the other counterpart.
Removal of the N-terminal peptide with caspase-8 could expose
the C-terminal PDZ-binding motif of the counterpart KRS which then
provides a docking site for syntenin (Fig. 13).
Second, this work suggested the third way for the KRS
dissociation from MSC. So far post-translational phosphorylation has
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been reported to trigger dissociation of KRS from MSC. For instance,
phosphorylation at T52 and S207 was responsible for membrane and
nuclear localization of KRS, respectively (Kim et al., 2012;
Yannay-Cohen et al., 2009). However, it was not known how KRS is
dissociated from MSC for its extracellular secretion. This work
showed a new way of KRS translocation. Namely, the dissociation
from MSC and extracellular secretion involve the N-terminal cleavage
by caspase-8-mediated and the C-terminal interaction with syntenin.
Third, the amount of HSP90 detected in isolated exosomes
showed a positive correlation with that of KRS (Fig. 5A, 5C and 7E).
Considering that secreted HSP90 is also known to work as an
immune stimulatory factor (Basu et al., 2000; Bohonowych et al.,
2014), it is possible that KRS exerts a synergistic activity with
HSP90 and other inflammatory factors present in exosomes. In fact,
we determined that KRS comprised ~1% of the total exosome
proteins (data not shown). Nonetheless, exosomes containing even
such a low KRS content showed immune stimulatory activity
comparable to the naked KRS at much higher levels (Fig. 11 and Fig.
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12), supporting the notion that KRS synergizes with other exosome
factors in immune cell modulation. 
Fourth, we suggest a new mechanism about exosomal secretion
of cytosolic proteins. There is overwhelming evidence that cytosolic
proteins are present in exosome (Raposo and Stoorvogel, 2013). There
are different deductions about how cytosol proteins are secreted.
First, cytosolic proteins are recruited with chaperones such as HSP90,
HSC70, PKM2, 14-3-3 epsilon that interact with exosomal membrane
proteins. Second, lipid modifications such as palmitoylation and
myristoylation of cytosolic proteins could be recruited to MVB
(Buschow et al., 2010; Shen et al., 2011). However, the exact
mechanism about exosomal secretion of cytosol protein is not
revealed. Our data shows cytosolic KRS protein secretes through
extracellular space in the syntenin dependent exosomal secretion
pathway. For this mechanism, secreted KRS protein uses its two
conserved sequence, N-terminal appended caspase cleavage sequence
and C-terminal PDZ binding sequence. Our data shows that secreted
KRS was truncated its N-terminal appended sequence by caspase-8.
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KRS N-terminal truncation induced the interaction with KRS
C-terminal PDZ binding domain and syntenin. When caspase-8 level
was decreased using siRNA, KRS secretion was also decreased. In
addition, the non-truncation mutant of KRS (D12A) secretion was
also decreased. It indicates two conserved domain collaborates for
KRS secretion. The exact mechanism is still unclear and further work
needs to be done. With this data, this paper highlights a novel
mechanism that syntenin recruits cytosolic proteins for exosomes
using their PDZ domain. Furthermore, caspase-8 supports this
mechanism.
Fifth, we present that caspase-8 cleavage of KRS and secreted
extracellular space that induce inflammation which supports the
hypothesis of caspase-8 has essential role in inflammation (Gurung
and Kanneganti, 2015). Caspase-8 is involved in apoptosis induced by
Fas and other apoptotic stimuli. Sequential activation of caspase-8 is
the key mediator of apoptosis. But recently literatures suggested that
caspase-8 play a non-apoptotic function in immune cell. Caspas-8 can
directly cleave pro-IL-1β in immune cell. In our data, cancer cell
increased caspase-8 in starvation condition (Figure. 8H). And
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performed that caspase-8 induced KRS N-terminal truncation process.
So under starvation condition, cancer cell maybe secretes KRS using
caspase-8. Although we should have further work this mechanism,
we showed that KRS is new target of caspase-8. Its N-terminal
truncation by caspase-8 is indispensable process for secretion (Figure.
8). And induced syntenin dependent exosome secretion (Figure. 5).
Finally, KRS exosomes induced by caspase-8 recruit
macrophage/neutrophils and activated these immune cell that secreted
TNF-alpha, IL-6, MMP9 (Figure. 11).
Syntenin is a trafficking protein using its tandem PDZ domains,
which play essential role to bind to other binding partners. Syntenin
is well-known adaptor protein for several transmembrane cargos.
Syntenin control diverse intracellular trafficking that recycling of
syndecans, biosynthetic trafficking of TGF-alpha, endocytosis of CD63
(Beekman and Coffer, 2008). KRS has PDZ binding domain in its
C-terminus (Figure. 5). We speculate that syntenin could bind
tetraspaniing molecualr, for example CD63, with KRS. For exosomal
secretion, syntenin should bind in endosome membrane. Tetraspanin
could help syntenin to bind endosome membrane. So KRS-syntenin
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complex translocates MSC to endosome membrane, binds tetraspanin
protein and produces ILV in MVB. Its mechanism should be solved in
further work.
This KRS truncation process and interaction with syntenin is
induced in starvation condition. Starvation condition induces cell cycle
arrest (Rosner and Hengstschlager, 2011), (Rosner et al., 2013). KRS
is one of the aminoacyl tRNA synthetase that are involved in
translational machinery. Many ARSs has a non-classical role, when
cells are placed in specific environment. When global translation was
stopped by starvation, KRS has a potential to do non classical
function. Already some ARS has a role in homeostasis regulation; we
estimate that KRS also perform to regulate homeostasis. Herein, we
anticipate that KRS exosome induced cancer cell apoptosis through
inflammation.
The identification of KRS as a substrate of caspase-8 suggests
unexpected connection of two enzymes, ARSs and caspases. While
apoptotic caspases are known to initiate programmed cell death, their
non-canonical activities beyond cell death have been also reported
(Creagh, 2014; Man and Kanneganti, 2016). Among them, caspase-8
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is shown to trigger inflammation by the activation of pro-IL1β,
pro-IL18 (Bossaller et al., 2012; Gringhuis et al., 2012). However, all
of these processes are known to take place in immune cells and it
was not known whether caspase-8 is also involved in inflammation
caused by cancers. Conversely, it remained unanswered what triggers
the secretion of KRS from cancer cells to provoke inflammation. This
work provides the clear answer to these unanswered questions and
suggests a functional connection between caspase-mediated signaling




Cell culture and materials.
HCT116 cells were cultured in RPMI medium (with 25 mM HEPES
buffer and L-glutamine, Hyclone), supplemented with 10% fetal
bovine serum (FBS) and 50 μg/ml penicillin and streptomycin, at
37°C in a 5% CO2 incubator. RAW 264.7 cells were culture din high
glucose Dulbecco`s modified Eagle’s medium (DMEM) (with 4mM
L-glutamine, 4.5 mg/ml glucose and sodium pyruvate,
Hyclone),supplemented with 10% fetal bovine serum (FBS) and 50
μg/ml penicillin and streptomycin, at 37°C in a 5% CO2 incubator.
Si-RNAs specific to syntenin (SC-42164) and stealth universal RNAi
(SC-37007) were purchased from SantaCruz Biotechnology, and those
for KRS (HSS105656), caspase-3 (HSS101372) ,-6 (HSS101378) ,-8
(HSS141461) ,-9 (HSS189012), stealth RNAi Negative Control Medium
GC Duplex (253001) were purchased from Invitrogen.They were
transfected using Lipofectamine2000 Transfection reagent (Invitrogen)
and X-tremeGENE HP DNA transfection reagent (Roche) following
the manufacturer`s protocol. The peptide inhibitors specific to
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caspase-3(Z-VAD-DQMD), -6 (Z-VAD-VEID), -8 (Z-VAD-IETD)
and -9 (Z-VAD-LEHD) were obtained from Calbiochem and added to
cells at 14 μM in serum-free conditions.
Plasmids
The N- and C-terminal Myc-tagged human KRS proteins were
cloned at the EcoRI/XhoI sites of pcDNA3 plasmid. The N-terminal
one Strep tag was inserted at the KpnI/BamHI sites of the
C-terminal Myc-tagged human KRS plasmid. The N-terminal
Myc-tagged human KRS mutants (△N10, △N20, △N30, △N40,
△N11 and △N12), and the C-terminal Myc-tagged human KRS
mutants (△C5), were cloned at the EcoRI/XhoI sites of pcDNA3
plasmid. pEGFP-KRS and the BiFC plasmids of pBiFC-VN173 (Flag
tag) and pBiFC-VC155 (HA tag) were previously described (Kim et
al., 2012; Kwon et al., 2011). pBiFC-VN173-KRS and
–VC155-syntenin were cloned at the HinDIII/XbaI (KRS),
EcoRI/EcoRI (syntenin) sites of pBiFC plasmids. The BiFC
N-terminal Renilla-KRS-C-terminal Renilla plasmid was a kind gift
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from Dr. Min Guo (The Scripps Research Institute, Florida, USA).
pmCherry-Alix plasmid was cloned at the EcoRI/BamHI sites of
pmCherry-C1 plasmid. The cDNAs encoding Myc-KRS, KRS-Myc,
and pBiFC-VN173-KRS mutant at D12A, C4A were cloned using a
QuikChange II kit (Agilent Technologies) following the manufacturer’s
instruction.
Immunoblotting and immunoprecipitation
Cells were lysed with 50 mM Tris-HCl buffer (pH 7.4) containing
150 mM NaCl, 10 mM NaF, 1 mM EDTA, 1% NP-40, 10% glycerol
and protease inhibitor. After 30 min, the supernatants were dissolved
in SDS sample buffer and separated by SDS-PAGE. Antibodies
against different ARSs were used for immunoblotting (Abcam).
Antibodies specific to Hsp90 (H-114), syntenin (S-31), CD63 (H-193),
Rab27a (E12A-1), GFP (B-2), Myc (9E10), caspase-3 (E-8), -6
(H-12), -8 (4.1.20), -9 (H-83), and HIF1-a (H-206) were purchased
from Santa Cruz biotechnology; those for Alix (3A9), BIP (C50B12),
p-S6K (Thr398, #9205), S6K (#9202), p-tyrosine (#9411), p-threonine
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(#9381) and IRE1-a (14C10) were purchased from Cell Signaling
Technology; p-IRE1-a (Ser724) was purchased from NOVUS
biologicals; and p-serine (p3430), beta-actin (A5441) were purchased
from Sigma-Aldrich. Active caspase-3 (C92-605) was purchased from
BD Pharmingen. For immunoprecipitation, cells were lysed at 4°C in
50 mM HEPES buffer (pH7.4) containing 150 mM NaCl, 0.5% NP-40,
2 mM EDTA, 5% glycerol, and protease inhibitor (Calbiochem). The
protein extracts were incubated with specific antibody for 2 h at 4°C
with agitation, then protein G agarose was added and further
incubated for 4 h. After centrifugation, the precipitated samples were
resuspended in cold lysis buffer and washed 3 times. Proteins were
eluted from the beads and separated by SDS-PAGE.
Determination of KRS secretion
HCT116 cells were cultivated to 60% confluency in RPMI containing
10% FBS (Hyclone). After cells were washed twice, they were
transferred to serum-free RPMI for 24 h. The culture media were
collected and centrifuged at 500 g for 10 min. The supernatants were
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centrifuged again at 10,000 g for 30 min to eliminate membrane
organelles, and then proteins were precipitated with 12% TCA and
incubated for 12 h at 4 ℃. Pellets were obtained by centrifugation at
18,000 g for 15 min and neutralized with 100 mM HEPES (pH 8.0).
Proteins in the pellets were separated by SDS/PAGE, and subjected
to immunoblotting with an anti-KRS antibody.
Exosome isolation
Media were obtained from HCT116 cells incubated in the complete
(RPMI containing 10% FBS) and starvation conditions (RPMI only)
and subjected to centrifugation at 500 g for 10 min to remove cells
and subsequently at 10,000 g for 30 min to remove debris. The
supernatants were then centrifuged at 100,000 g for 1.5 h to
precipitate exosomes. Protein content of the isolated exosomes was
quantified by Bradford assay.
Opti-prep density gradient assay and dynamic light scattering
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Purified exosomes were loaded onto continuous OptiPrep Density
Gradient Medium (Sigma-Aldrich) (40, 20, 10 and 5% iodixanol
solution with 0.25 M sucrose and 10 mM Tris-HCl, pH7.5) and
centrifuged at 150,000 g for 15 h. The ten fractions were harvested
and proteins in each fraction obtained by TCA precipitation. Proteins
of interest were detected by immunoblot analysis. The size of the
secreted vesicles was measured by an ELS-Z light scattering
spectrophotometer (Otsuka Electronics, Japan).
Gel filtration chromatography
HCT116 cells were lysed with 10 mM HEPES buffer (pH 7.4)
containing 10 mM KCl, 100 μM EDTA, 1 mM DTT, 0.4% Nonidet
P-40 and protease inhibitor mixture. Cell lysates were centrifuged at
13,000 rpm for 15 min, and the supernatants transferred to a new
tube. The supernatants (4 mg total proteins in 400 ml) were injected
into a Superdex200 chromatography column 10/300 GL (GE
Healthcare) in an AKTA FPLC system (Amersham Pharmacia
Biotech). The separated proteins were then resolved by SDS/PAGE
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and subjected to immunoblotting with antibodies specific to the
indicated proteins.
Preparation of human full-length and truncated KRS
The cDNAs for human cytosolic KRS (1-597aa WT and N-terminal
12aa truncated) were subcloned into pET-28a (Novagen) with EcoRI
and XhoI, and expressed in Escherichia coli BL21 (DE3). His-tagged
KRS was then purified using nickel affinity (Invitrogen) and Mono Q
ion-exchange chromatography, following the manufacturer’s
instructions. To remove lipopolysaccharide (LPS), the KRS solution
was dialyzed in pyrogen-free buffer and subsequently filtered through
Acrodisc Units with Mustang E membrane, 0.2 mm, 25 mm (Pall
Corporation) in PBS containing 20% glycerol.
TNF-α ELISA assay
RAW264.7 cells (2x104) were cultured on 24-wel lplates containing
DMEM with 10% FBS and 1% antibiotics for 12h, and treated with
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the purified KRS at the indicated concentrations for 6h.The media
were harvested after centrifugation at 3,000g for 5 min and the
secreted TNF-α was measured using a TNF-α ELISA kit (BD
Pharmingen), following the manufacturer’s instruction.
BiFC immunofluorescene staining
HCT116 cells expressing KRS-VN173, syntenin-VC155, and
mCherry-Alix were incubated in starvation condition with or without
caspase-8 inhibitor. The cells were fixed on 9 mm coverslip with 4%
paraformaldehyde and permeabilized with 0.1% Triton X-100 for 5
min and washed briefly with cold phosphate buffer saline (PBS).
After a 10 min incubation with the CAS-Block (Invitrogen) for
blocking, the cells were incubated for 1 h with an anti-Flag antibody.
Alexa 555 (Invitrogen) was then added for 1 h at room temperature
and cells DAPI stained for 10 min. After washing with cold PBS for
30 min, the specimens were observed by laser-scanning microscopy.
The mounted samples were visualized at room temperature by
confocal fluorescence microscope (A1 Rsi, Nikon) through an objective
72
lens (Plan Apochromat VC 60X, Nikon) and with NIS-Elements
AR3.2 64 bit program. For live cell time-lapse microscopy, HCT116
cells expressing KRS-VN173 and syntenin-VC155 were seeded in a
glass-bottom 2-well imaging chamber (Lab-Tek II, Thermo Fisher
Scientific) containing RPMI with 10% FBS, and incubated using
On-Stage Cell Incubation system (Live Cell Instrument) at 37 oC with
5% CO2 for 12h. Cells were then starved for 3h at 37 °C and images
were collected at 3 min intervals.The samples were visualized by
confocal fluorescence microscope (A1Rsi, Nikon) through an objective
lens (Plan Apochromat VC20XN. A0.75,Nikon) and EM-CCD camera
(iXonEM CCD camera DU897E #BV,Andor).
Wound healing migration assay
RAW 246.7 cells (4x104) were seeded in 12-well cell culture plate in
complete growth media and incubated until a confluent monolayer
was formed. The monolayer of cells was wounded by manual
scratching with a pipet tip, washed with PBS, and media containing
either KRS WT, △N12 (6 mg/ml) protein, or KRS-exosomes (0.05,
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0.5, 5 mg/ml) were added. After 12 h, the wound regions were
photographed by phase contrast microscopy (C1, Nikon) through an
objective lens (Plan Apo 10X), EM-CCD camera (DU-897, Andor)
and with NZS-C4.11 program.
Transwell migration assay
A 24-well plate transwell chamber with 5.0 mm polycarbonate
membrane (Costar) was used for cell migration assays. The inserts
were coated with 10 ml of 0.5 mg/ml of gelatin (Sigma-Aldrich) and
dried overnight under UV light. RAW264.7 cells were cultured in the
bottom chamber. After 12 h, culture media were changed to
serum-free DMEM, added to the inserts (1x105cells),and treated with
BSA (100nM), KRS protein (6mg/ml), and KRS-exosomes (5 mg/ml)
purified from HCT116 cells treated with control siRNA or
KRS-specific siRNA for 8 h at 37 oC in a 5% CO2 incubator. The
inserts were washed twice with cold PBS and the cells fixed in 70 %
methanol and 30% PBS solution for 30 min. After washing the
inserts with PBS three times, the cells were fixed using hematoxylin
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(Sigma-Aldrich) for 30min. The inserts were washed with distilled
water three times and then on-migrant cells removed with a c ottons
wab. The membranes were extracted using a blade and mounted to
amicroslide using GelMount (Biomeda). Images of the migrating cells
were taken with Optical microscope (20X, KoreaLabTech) using the
Topview 3.5program.
Intravital imaging
A custom-built laser-scanning confocal microscope modified from a
previously constructed system (Choe et al., 2013) was used to
visualize macrophage/neutrophil recruitment. Three CW lasers at 488
nm (MLD488 60 mW, Cobolt), 561 nm (Jive 50 mW, Cobolt) and 640
nm (MLD640 100 mW, Cobolt) were used as excitation source. To
implement 2D scanning, a fast-rotating polygonal mirror (MC-5,
aluminum coated, Lincoln Laser) and galvanometer (6230H, Cambridge
Technology) were used. High-sensitivity photomultiplier tubes (R9110,
Hamamatsu) were used to detect three-color fluorescence signals
simultaneously. Three detection channels were split by dichroic
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mirrors (FF01-442/46-25, FF02-525/50-25, FF01-585/40-25,
FF01-685/40-25, Semrock) and bandpass filters (FF484-FDi01,
FF560-Di01, FF649-Di01, Semrock). Electric signals obtained from
photomultiplier tube were digitized by an 8-bit 3-channel frame
grabber (Solios, Matrox). The field of view (FOV) of images obtained
by the 20X objective (LUMFLN60XW, NA1.1, Olympus) was 500x500
μm2. After acquisition from the imaging system, 512x512 pixel images
were then XY-shift compensated with Matlab (Mathworks). During
the imaging, a motorized XYZ translational stage (MPC-200-ROE,
Sutter Instrument), which has 1μm resolution, was used to precisely
adjust sample position.
LysM-GFP (Lysozyme M-GFP) mice (Faust et al., 2000) that
endogenously express GFP in macrophages and neutrophils were
used. 12-20 week old male LysM-GFP mice were deeply
anaesthetized with intraperitoneal injection of Zoletil (30 mg/kg) and
Rompun (10 mg/kg). During imaging, mouse body temperature was
maintained at 37°C with a homoeothermic controller (PhysioSuite,
RightTemp, Kent Scientific). To avoid immune responses caused by
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hair removal, mouse ear skin was shaved at least 12 h before
imaging.
B16F10 cells were transfected with myc-KRS, KRS-Myc
(WT and D12A Mutant) and empty vector using Lipofectamine 2000
(Invitrogen). The transfected B16F10 cells were then fluorescently
labeled with the lipophilic fluorescent dye, Vybrant DiI, or DiD
solution (Thermo Fisher Scientific) by incubating with 5 μl of DiI or
DiD solution per ml of cell media for 1 h. After washing with PBS
three times, labeled cells were prepared in PBS solution and
intradermally injected into mouse ear skin (4x104cells/μl) with a 31 G
microinjector. To visualize macrophage/neutrophil recruitment along
the cell injection site, time-lapse images were taken at 30 sec
intervals after injection.
HCT116 cells were transfected with control siRNA (Si-con)
and KRS-specific siRNA (si-KRS) using X-tremeGENE HP DNA
transfection reagent (Roche), following the manufacturer`s protocol.
The transfected HCT116 cells were incubated with DiI (5 μl/ml) for 1
h. After washing with PBS, the labeled cells were incubated in
starvation condition for 24 h. Si-con, si-KRS exosomes were purified
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from incubation media using the exosome isolation method described
above. Exosomes were intradermally injected into mouse ear skin (0.1
μg/μl) with 31 G microinjector. Time-lapse images were taken at 30
sec intervals after injection.
Luminex screening assays (bead-based multiplex kits)
RAW 246.7 cells were cultured in 12-well plate in DMEM with 10%
FBS and 1% antibiotics for 12 h and starved in serum-free media for
2 h. Different amounts of KRS (WT and △N12 mutant, 6 mg/ml)
and KRS-exosomes (5 mg/ml) were added to the media. At different
time intervals, the media were collected and subjected to
centrifugation at 3,000 g for 10 min. For the multiplex assay, the
secretion of TNF-α, mCRG-2, IL-6, mIL-1b, mIL-12, mIL-10, MMP9,
INF-γ, mMIP3a and CXCL10 was measured using premixed beads
purchased from R&D Science, following manufacturer’s instructions,
and quantified by BioRad Bioplex 200 system and software.
Renilla BiFC luciferase assay
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BiFC Renilla luciferase KRS vector (provided by Dr. Min Guo, The
Scripps Research Institute, Florida, USA), which the N- and
C-terminal domains of Renilla luciferase were fused to the N- and
C-terminal ends of KRS, was co-transfected into HCT116 cells, along
with the firefly luciferase vector. After 24 h, cells were incubated in
each starvation condition with or without caspase-8 inhibitor.
Luciferase activity was measured using a luciferase assay kit
(Promega) and luminometer.
Immunogold-label electron microscopy
Exosomes isolated from starved HCT116 cells and exosome-treated
macrophages were fixed with 2.5% glutaaldehyde and 2% osmium
tetroxide for 1 h at 4 °C. They were then dehydrated with a graded
acetone series and embedded into Spurr’s medium (EMS). The
sections were made in 60 nm thickness horizontally to the plane of
the samples using an ultramicrotome (RMC MTXL) and mounted on
nickel grids. Free aldehyde groups were quenched with 0.02 M
glycine for 10 min. Sections were then rinsed in deionized water,
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floated for 1 h in PBS containing 1% BSA, and incubated directly in
the primary rabbit antibodies at 4°C for 1 h. Sections were rinsed
several times with PBS-BSA (0.1% BSA in PBS) and floated for 1 h
in the rabbit IgG conjugated to 10 nm gold particles (Sigma-Aldrich)
diluted 1:50 in PBS-BSA. The gold particle-labelled sections were
counterstained with uranyl acetate and lead citrate. For immunogold
staining of KRS in multivesicular body (MVB), HCT116 cells were
incubated in serum free RPMI1640 medium for 3 h, and then cells
collected by low-speed centrifugation. Following the preparative steps
of cryo-fixation (Donohoe et al., 2007), the prepared sections were
examined using a Hitachi H-7600 (Hitachi, operating at at 80 k) and
a JEM-1400 PLUS Transmission Electron Microscope (JEOL)
Statistical methods
The Student's t-test was used for statistical anlaysis. P-value <0.05
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국문초록
염증성 암세포에서의 caspase-8에 의존적인 lysyl tRNA syntetase의
exosome을 통한 분비 기전 연구
Lysyl-tRNA synthetase (KRS)은 본래 multi-tRNA synthetase(MSC)에
결합하여 단백질 합성에 관여하는 단백질로 알려져 있다. 또한 암세포
밖으로 분비 된 KRS는 대식세포로 인한 염증 반응을 유발 하는
것으로도 알려져 있다. 그러나 염증을 유발하는 KRS의 그 분비 기전에
대해서는 아직 알려져 있지 않다. 본 졸업논문에서는 KRS가 exosome을
통해서 암 세포로부터 분비되는 것으로 밝혔다. 세포 밖으로 분비되는
KRS는 exosome lumen 내에 위치하며, 대식세포 근처에서 exosome이
파열 되면서 exosome 밖으로 나와 대식세포를 자극하는것으로
나타났다. 기아 상태의 암세포에서 KRS의 N- 말단 12 아미노산
펩티드가 caspase-8에 의해 절단된다. N- 말단이 절단된 KRS는 KRS의
C- 말단에 있는 PDZ 결합 모티프를 노출시키게 된다. Syntenin은
KRS의 노출된 PDZ 결합 모티프와 결합하여 MSC와 결합되어 있는
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KRS의 해리를 촉진 시켜서 exosome을 통한 분비가 이루어지게 한다.
KRS를 가지고 있는 exosome은 대식세포의 이동과 TNF-α 분비를
유도하며 이 효과에 KRS는 크게 기여하고 있다. 본 졸업논문은 KRS를
통해서 aminoacyl tRNA synthetase의 분비 경로를 확립한 첫 논문이며,
암 세포에서 일어나는 caspase-8을 통한 염증반응에서 KRS의 잠재적
역할을 입증하였다.
주요어 : exosome, lysyl-trna synthetase, syntenin, caspase-8,
inflammation
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